United States · FDA National Drug Code directory
Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 55111-272_45f79372-39c7-ae59-c119-51aece645ae0
- Product NDC
- 55111-272
- Form
- TABLET, COATED
- Composition / generic term
- Naproxen Sodium
- Labeler
- Dr.Reddy's Laboratories Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19980729
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (55111-272-01) / 100 TABLET, COATED in 1 BOTTLE · 55111-272-01
- 1 BOTTLE in 1 CARTON (55111-272-02) / 200 TABLET, COATED in 1 BOTTLE · 55111-272-02
- 1 BOTTLE in 1 CARTON (55111-272-05) / 500 TABLET, COATED in 1 BOTTLE · 55111-272-05
- 1 BOTTLE in 1 CARTON (55111-272-24) / 24 TABLET, COATED in 1 BOTTLE · 55111-272-24
- 1 BOTTLE in 1 CARTON (55111-272-50) / 50 TABLET, COATED in 1 BOTTLE · 55111-272-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →